Introduction: Current literature suggests that vascular components play a fundamental role in
neurological diseases like Alzheimer’s disease (AD) (Kovacic and Fuster, 2012). One such
component is erythrocytes (RBCs) that are highly deformable, which contributes to assisting
blood flow in the microcirculation (Mohandas and Gallagher, 2008). Abnormalities in RBCs and
their flow can contribute to AD by obstructing oxygen delivery to parts of the brain that are
already in a compromised state. Closely linked to hematological pathology in AD are increased
iron levels that may play an important role in the pathogenesis of the condition(Barnham and
Bush, 2008). Increased iron levels cause oxidative stress, as they participate in
oxygen-dependent free radical formation (Castellani et al., 2012). This free radical stress may
have an impact on RBCs and may possibly cause extensive and accumulative damage to these
cells, ultimately compromising their functioning. Aims: Determine if there is iron overload
present in AD and if this has an effect on the structure of the RBCs. Methods: 25 AD patients
and 40 healthy control individuals were studied and results from light microscopy, scanning
electron microscopy, atomic force microscopy and confocal microscopy were correlated.
Results: RBC ultrastructure showed a changed morphology in the presence of iron overload.
These changes might impair the oxygen carrying capacity and compromise hemorheology of
the RBCs, and additionally cause a strain on the already challenged brain function of these
individuals. Conclusions: Iron overload are present in AD patients, this may cause the condition
to progress faster than in AD individuals who do not have iron overload, particularly due to the
additional hydroxyl radical load.
References:
Kovacic,J.C.,andFuster,V.(2012). Atherosclerotic risk factors, vascular cognitive impairment, and Alzheimer disease. Mt. SinaiJ.Med. 79, 664–673.
Mohandas,N.,andGallagher,P.G.(2008) .Red cell membrane:past,present,and future. Blood 112, 3939–3948.
Barnham,K.J.,andBush,A.I.(2008). Metals in Alzheimer’s and Parkinson’s diseases. Curr.Opin.Chem.Biol. 12, 222–228.
Castellani,R.J.,Moreira,P.I.,Perry,G.,andZhu,X.(2012). The role of iron as a mediator of oxidative stress in Alzheimer disease. Biofactors 38, 133–138.
We would like to acknowledge Dr Prashilla Soma who drew our blood
samples and Dr Wiebren Duim (Neurologist) who gave us insights regarding the Alzheimer’s
patient sample. Also, we are in debt to the family members of the patients who gave informed
consent for the study.